Inventor · disambiguated record
Valeriya Smolenskaya
Also filed as: SMOLENSKAYA VALERIYA · SMOLENSKAYA VALERIYA N · SMOLENSKAYA VALERIYA NIKOLAYEVNA
18 granted patents·6 pending applications·45 citations·filing 2007–2025
93Inventor score
Files withGILEAD SCIENCES INC5CELGENE CORP3OTSUKA AMERICA PHARMACEUTICAL INC3NEUROVANCE INC2NEWAMSTERDAM PHARMA B V2
Top patents by PatentIndex Score
24 records- 0189US10508117B2Solid forms of a toll-like receptor modulatorGILEAD SCIENCES INC·Filed 2018·Granted Dec 17, 2019·5 cites·18 claims
- 0289US9643956B2Solid forms of an ASK1 inhibitorGILEAD SCIENCES INC·Filed 2015·Granted May 9, 2017·9 cites·81 claims
- 0388US9708261B2Crystalline compoundsNEUROVANCE INC·Filed 2016·Granted Jul 18, 2017·6 cites·32 claims
- 0487US10800740B2Crystalline compoundsOTSUKA AMERICA PHARMACEUTICAL INC·Filed 2019·Granted Oct 13, 2020·2 cites·26 claims
- 0586US9856217B2Crystalline compoundsNEUROVANCE INC·Filed 2017·Granted Jan 2, 2018·4 cites·14 claims
- 0685US11299458B2Crystalline compoundsOTSUKA AMERICA PHARMACEUTICAL INC·Filed 2020·Granted Apr 12, 2022·1 cites·10 claims
- 0784US10280141B2Crystalline compoundsOTSUKA AMERICA PHARMACEUTICAL INC·Filed 2017·Granted May 7, 2019·3 cites·40 claims
- 0882US9624271B2Romidepsin solid forms and uses thereofCELGENE CORP·Filed 2015·Granted Apr 18, 2017·2 cites·16 claims
- 0981US9102680B2Crystal forms of (R)-N-methylnaltrexone bromide and uses thereofPROGENICS PHARM INC·Filed 2012·Granted Aug 11, 2015·4 cites·14 claims
- 1080US10946004B2Solid forms of an ASK1 inhibitorGILEAD SCIENCES INC·Filed 2019·Granted Mar 16, 2021·2 cites·8 claims
- 1177US12378221B2Salts of obicetrapib and processes for their manufacture and intermediates thereofNEWAMSTERDAM PHARMA B V·Filed 2024·Granted Aug 5, 2025·0 cites·22 claims
- 1276US11773098B2Solid forms of a toll-like receptor modulatorGILEAD SCIENCES INC·Filed 2021·Granted Oct 3, 2023·0 cites·20 claims
- 1374US8980825B2Romidepsin solid forms and uses thereofCELGENE CORP·Filed 2014·Granted Mar 17, 2015·1 cites·2 claims
- 1472US9879024B2Crystal forms of (R)-N-methylnaltrexone bromide and uses thereofPROGENICS PHARM INC·Filed 2015·Granted Jan 30, 2018·1 cites·30 claims
- 1571US9585892B2Solid forms comprising N-(5-tert-butyl-isoxazol-3-yl)-N′-{4-[7-(2-morpholin-4-yl-ethoxy)imidazo[2,1-b][1,3]benzothiazol-2-yl]phenyl}urea, compositions thereof, and uses therewithAMBIT BIOSCIENCES CORP·Filed 2014·Granted Mar 7, 2017·1 cites·20 claims
- 1669US8883783B2Solid forms comprising N-(5-tert-butyl-isoxazol-3-yl)-N′-{4-[7-(2-morpholin-4-yl-ethoxy)imidazo[2,1-b][1,3]benzothiazol-2-yl]phenyl}urea, compositions thereof, and uses therewithBHAGWAT SHRIPAD S·Filed 2008·Granted Nov 11, 2014·2 cites·23 claims
- 1761US8883802B2Co-crystals of a triazolo [4,5-D] pyrimide platelet aggregation inhibitorCOSGROVE STEPHEN DAVID·Filed 2010·Granted Nov 11, 2014·2 cites·16 claims
- 1860US2010305323A1Crystal forms of (r)-n-methylnaltrexone bromide and uses thereofSMOLENSKAYA VALERIYA N·Filed 2008·Application pending·0 cites
- 1957US9518094B2Romidepsin solid forms and uses thereofCELGENE CORP·Filed 2015·Granted Dec 13, 2016·0 cites·6 claims
- 2056US2018243281A1Solid forms of an ask1 inhibitorGILEAD SCIENCES INC·Filed 2018·Application pending·0 cites
- 2149US2012190817A2Romidepsin solid forms and uses thereofHANKO JASON·Filed 2011·Application pending·0 cites
- 2249US2010113550A1New Crystal FormsBIAL PORTELA AND CA S A·Filed 2007·Application pending·0 cites
- 2345US2011053997A1Salts and Crystal FormsBELIAEV ALEXANDER·Filed 2008·Application pending·0 cites
- 2445US2025186442A1Obicetrapib and Ezetimibe Combination Treatment and Fixed Dose Pharmaceutical CompositionsNEWAMSTERDAM PHARMA B V·Filed 2025·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →